Here, hepatologists explain what it is and why they completely warn against it. If you are one of the two in five U.S. adults with obesity, having a goal to lose weight in a healthy way is certainly ...
Heart disease continues to be the world's biggest killer. Yet, one of the most important shifts happening in medicine today isn't in the operation theatre, it ...
One potential use of GLP-1s catching scientists’ eye is the management of autoimmune disease, a general term for a health ...
This guide explores how GLP-1 medications may affect weight management, metabolic health and certain menopause-related health ...
Bangladesh's decades-long fight against hepatitis B and C is showing positive results, but health experts warn the country is ...
20h
Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder ...
Japan Prime Minister Sanae Takaichi's admission of surviving on just zero to three hours of sleep has sparked health concerns ...
The Therapeutic Goods Administration has issued a safety warning for a rare, but serious risk of vision impairment from ...
Catherine L’Estrange was diagnosed with a rare genetic condition as a baby and hopes the treatment will allow her to keep ...
The contentious debate around semaglutide in South African healthcare extends beyond its use for obesity and type 2 diabetes, ...
Doctors urge people to treat stroke as a medical emergency, warning every minute costs brain cells. Controlling diabetes, hypertension and unhealthy habits, and reaching hospital quickly, can save ...
A new study linked GLP-1 weight loss drugs, including Ozempic, Wegovy and Mounjaro, to a higher risk of hair loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results